TSG Advice Partners’s Amgen AMGN Stock Holding History

TSG Advice Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$250K	Buy	709 +69	+11%	+$24.6K	0.04%	123
2025 Q4	$210K	Buy	+640	New	+$203K	0.03%	109

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

TSG Advice Partners's AMGN Position: Q1 2026 in Review

TSG Advice Partners increased its Amgen (AMGN) stake by 11% in Q1 2026, buying an estimated $24.6K and bringing the position to 709 shares worth $250K. The position accounts for 0.04% of the portfolio, ranked #123.

TSG Advice Partners first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

TSG Advice Partners held 709 shares of Amgen worth $250K as of Q1 2026.
TSG Advice Partners bought 69 Amgen shares in Q1 2026, an estimated $24.6K.
Amgen made up 0.04% of TSG Advice Partners's portfolio in Q1 2026, its #123 holding.
TSG Advice Partners first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on TSG Advice Partners's 13F filing for Q1 2026, filed 24 Apr 2026.